13F

Stock

Theravance Biopharma, Inc.

TBPH · held by 1 managers

Reported value

$397.1K

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$8.74K

Price effect on 1 books still in the name

Largest holder

$397.1K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC36.6K$397.1K−$8.74KAdded$132.1K

Positions as of Q1 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.